This company has been marked as potentially delisted and may not be actively trading. Jupiter Neurosciences (JUNS) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesTrendsBuy This Stock JUNS vs. CRGX, TIL, GNFT, OGI, MGRM, ZEPP, EPRX, TVGN, CTMX, and ELDNShould you be buying Jupiter Neurosciences stock or one of its competitors? The main competitors of Jupiter Neurosciences include CARGO Therapeutics (CRGX), Instil Bio (TIL), GENFIT (GNFT), Organigram Global (OGI), Monogram Orthopaedics (MGRM), Zepp Health (ZEPP), Eupraxia Pharmaceuticals (EPRX), Semper Paratus Acquisition (TVGN), CytomX Therapeutics (CTMX), and Eledon Pharmaceuticals (ELDN). These companies are all part of the "medical" sector. Jupiter Neurosciences vs. Its Competitors CARGO Therapeutics Instil Bio GENFIT Organigram Global Monogram Orthopaedics Zepp Health Eupraxia Pharmaceuticals Semper Paratus Acquisition CytomX Therapeutics Eledon Pharmaceuticals Jupiter Neurosciences (NASDAQ:JUNS) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations. Do insiders and institutionals have more ownership in JUNS or CRGX? 93.2% of CARGO Therapeutics shares are owned by institutional investors. 2.9% of CARGO Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media prefer JUNS or CRGX? In the previous week, CARGO Therapeutics had 2 more articles in the media than Jupiter Neurosciences. MarketBeat recorded 2 mentions for CARGO Therapeutics and 0 mentions for Jupiter Neurosciences. CARGO Therapeutics' average media sentiment score of 1.08 beat Jupiter Neurosciences' score of 0.94 indicating that CARGO Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Jupiter Neurosciences Positive CARGO Therapeutics Positive Do analysts recommend JUNS or CRGX? CARGO Therapeutics has a consensus price target of $15.40, indicating a potential upside of 242.98%. Given CARGO Therapeutics' higher possible upside, analysts plainly believe CARGO Therapeutics is more favorable than Jupiter Neurosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jupiter Neurosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00CARGO Therapeutics 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 Is JUNS or CRGX more profitable? Jupiter Neurosciences' return on equity of 0.00% beat CARGO Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Jupiter NeurosciencesN/A N/A N/A CARGO Therapeutics N/A -45.93%-39.58% Which has stronger valuation & earnings, JUNS or CRGX? Jupiter Neurosciences has higher revenue and earnings than CARGO Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJupiter Neurosciences$230K195.72-$2.44MN/AN/ACARGO TherapeuticsN/AN/A-$167.50M-$4.62-0.97 SummaryJupiter Neurosciences beats CARGO Therapeutics on 6 of the 11 factors compared between the two stocks. Get Jupiter Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for JUNS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JUNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JUNS vs. The Competition Export to ExcelMetricJupiter NeurosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$45.02M$2.49B$5.48B$9.54BDividend YieldN/A1.81%4.73%4.09%P/E RatioN/A8.9728.8623.83Price / Sales195.72433.83371.4566.14Price / CashN/A157.7635.4557.96Price / Book10.464.838.265.54Net Income-$2.44M$31.62M$3.25B$259.28M Jupiter Neurosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JUNSJupiter NeurosciencesN/A$1.36-2.9%N/AN/A$45.02M$230K0.005Analyst UpgradeGap DownCRGXCARGO Therapeutics2.3047 of 5 stars$4.50-0.4%$15.40+242.2%-73.1%$208.42MN/A-0.97116TILInstil Bio3.0416 of 5 stars$29.69-6.3%$119.00+300.8%+78.6%$207.85MN/A-2.48410News CoverageGNFTGENFIT1.7165 of 5 stars$4.16+0.5%$13.00+212.5%-8.9%$207.01M$76.77M0.00120News CoverageOGIOrganigram Global1.4692 of 5 stars$1.48-3.3%N/A-15.3%$204.93M$117.47M14.80860News CoverageMGRMMonogram Orthopaedics1.323 of 5 stars$5.69+0.2%$5.40-5.1%+128.4%$202.71M$370K-12.6428News CoverageZEPPZepp Health1.1746 of 5 stars$13.64+22.6%$13.87+1.7%+451.9%$199.07M$181.18M-2.721,230Negative NewsUpcoming EarningsShort Interest ↑Gap DownEPRXEupraxia Pharmaceuticals2.7393 of 5 stars$5.64+2.7%$11.00+95.2%+85.5%$197.40MN/A-7.4229Upcoming EarningsHigh Trading VolumeTVGNSemper Paratus Acquisition3.4937 of 5 stars$1.08+1.9%$10.00+825.9%+61.5%$194.93MN/A0.003News CoverageUpcoming EarningsShort Interest ↑CTMXCytomX Therapeutics3.9885 of 5 stars$2.39-0.4%$5.33+123.2%+75.4%$193.49M$138.10M4.98170News CoverageUpcoming EarningsAnalyst ForecastELDNEledon Pharmaceuticals2.1589 of 5 stars$3.23-10.8%$10.00+209.6%+17.0%$193.42MN/A-1.5410Gap UpHigh Trading Volume Related Companies and Tools Related Companies CRGX Competitors TIL Competitors GNFT Competitors OGI Competitors MGRM Competitors ZEPP Competitors EPRX Competitors TVGN Competitors CTMX Competitors ELDN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JUNS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jupiter Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jupiter Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JUNS Stock Alerts